Core Viewpoint - Dingyang Technology announced the launch of its high-end compact high-resolution digital oscilloscope series SDS7000L, featuring a maximum bandwidth of 8GHz and 12-bit resolution, enhancing its product matrix and application scope [1] Group 1: Product Details - The SDS7000L series is designed with a 2U standard rack size, allowing for efficient cabinet installation and supporting dense deployment of multiple devices [1] - The product is suitable for various applications in industrial automation, telecommunications, and renewable energy sectors [1] Group 2: Strategic Implications - The introduction of this high-end product will help to consolidate and enhance the company's overall competitiveness in the market [1]

证券代码：688112 证券简称：鼎阳科技 公告编号：2025-018 深圳市鼎阳科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 05 月 22 日 （二） 股东会召开的地点：深圳市宝安区新安街道兴东社区安通达工业园 5 栋 1 层会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 49 | | --- | --- | | 普通股股东人数 | 49 | | 2、出席会议的股东所持有的表决权数量 | 115,322,803 | | 普通股股东所持有表决权数量 | 115,322,803 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例 | 72.4389 | | （%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 72.4389 | ...

上海市锦天城（深圳）律师事务所 法律意见书 上海市锦天城（深圳）律师事务所 关于深圳市鼎阳科技股份有限公司 2024 年年度股东大会的 法律意见书 地址：深圳市福田中心区福华三路卓越世纪中心 1 号楼 21-23 层 电话：0755-82816698 传真：0755-82816898 上海市锦天城（深圳）律师事务所 法律意见书 上海市锦天城（深圳）律师事务所 关于深圳市鼎阳科技股份有限公司 2024 年年度股东大会的 法律意见书 致：深圳市鼎阳科技股份有限公司 上海市锦天城（深圳）律师事务所（以下简称"本所"）接受深圳市鼎阳科 技股份有限公司（以下简称"公司"）的委托，指派律师出席公司 2024 年年度 股东大会（以下简称"本次股东大会"），并根据《中华人民共和国公司法》（以 下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司股东大会规则》（以下简称"《股东大会规则》"）等法律、法规和 规范性文件以及现行有效的《深圳市鼎阳科技股份有限公司章程》（以下简称"《公 司章程》"）的相关规定，对本次股东大会相关法律事项进行见证并出具本法律 意见书。公司已向本所提供了本所律师为出具 ...

Group 1 - Lingyun Optics' actual controller promises not to reduce shareholdings for 12 months starting from July 7, 2025 [1] - Chengdi Xiangjiang's subsidiary signed a contract with China Mobile for a data center project worth 1.632 billion yuan, with a 92-day construction period starting April 30, 2025 [1] - Dingyang Technology launched a high-end arbitrary waveform generator with a maximum output frequency of 5 GHz, catering to communication, industrial, and research testing needs [2][3] Group 2 - Heng Rui Medicine completed a share repurchase plan, buying back 12.9051 million shares for 601 million yuan, representing 0.20% of total shares [4][5] - ST Xiangxue received approval for clinical trials of TAEST1901 injection for treating advanced gastric cancer [5] - Yuyue Medical's subsidiary received EU MDR certification for its AED product, valid until May 11, 2030 [6][7] Group 3 - HNA Holding reported a 10.33% year-on-year increase in passenger revenue kilometers for April [8] - Springhui Zhikong's subsidiary terminated its listing on the National Equities Exchange and Quotations [9] - Delin Hai's shareholder plans to reduce holdings by up to 3%, equating to 3.39 million shares [10] Group 4 - Weiye Co. announced that two shareholders plan to reduce their holdings by up to 2% [12] - Green Alliance Technology's major shareholder intends to reduce holdings by up to 3% [14] - Luzhou Development Group increased its stake in Luzhou Tianhua by 1.02%, acquiring 15.9557 million shares [16] Group 5 - Hualan Pharmaceutical's subsidiary plans to acquire a 42.82% stake in Sanjing Qianhe for 23.446 million yuan [17] - Ganfeng Lithium's directors and executives plan to invest 30.8 million yuan in Shenzhen Yichu [19] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project [20] Group 6 - Jinkai Biotechnology's Blue Zone Fund plans to reduce holdings by up to 3% [21] - Hangxin Technology's former controlling shareholder intends to reduce holdings by up to 3% [22] - Galaxy Magnet's director plans to reduce holdings by up to 0.79% [23] Group 7 - Zhuoyue Technology's controlling shareholder's shares will be auctioned due to judicial proceedings [24] - Xinwufeng is forming a joint venture with France's Coplison Group with a registered capital of 80 million yuan [25] - Zhongcheng Co. is planning to issue shares to acquire 100% of a clean energy company, leading to a temporary stock suspension [26][27]

证券代码：688112 证券简称：鼎阳科技 公告编号：2025-017 | 产品名称 | 产品型号 | 产品性能指标 | | --- | --- | --- | | | | 最高输出频率： 5 GHz | | | | 调制带宽：2 GHz | | 系列任 SDG8000A | SDG8002A | 最大采样率：12 GSa/s | | 意波形发生器 | SDG8004A | 最大通道数量：4 | | | | 垂直分辨率：16-bit | | | | 最大任意波形长度：4Gpts/Ch | 二、新产品对公司的影响 深圳市鼎阳科技股份有限公司 关于自愿披露公司发布新产品的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、新产品基本情况 SDG8000A 系列高端任意波形发生器最高输出频率达 5 GHz，最大调制带 宽可达 2GHz，具备最大 4 个模拟输出通道，且每通道存储深度最高达 4 Gpts， 拥有高频高精度、自由波形编辑以及全面的调制与协议支持能力。 该系列产品提供高速串行码型信号输出，支持复 ...

Group 1 - The core viewpoint of the news highlights the significant growth of Dingyang Technology, with a 93% year-on-year increase in revenue for Q1 2025, driven by a successful high-end development strategy [1] - Dingyang Technology's high-end product revenue share increased to 29%, up by 8.85 percentage points year-on-year, indicating a strong market position [1] - The company has implemented a "produce one generation, research one generation, reserve one generation" R&D strategy, continuously launching more competitive high-end products [1] Group 2 - The market sizes for spectrum analyzers, signal generators, and vector network analyzers are reported as $1.403 billion, $905 million, and $784 million respectively, with projected compound annual growth rates (CGR) of 6.80%, 5.89%, and 6.37% from 2022 to 2027 [1] - In 2024, Dingyang Technology's direct sales revenue is projected to be 75.67 million yuan, accounting for 15.21% of total revenue, reflecting a year-on-year increase of 1.69 percentage points [1]

Investment Rating - The investment rating for the company is "Outperform the Market" [6][4]. Core Views - The company achieved a revenue growth of 2.93% year-on-year in 2024, with a significant decline in net profit by 27.79% due to high R&D and sales expenses, increased exchange losses, and reduced government subsidies [1][4]. - The first quarter of 2025 showed a strong recovery with a revenue increase of 26.93% and a net profit increase of 33.96%, driven by the growth in high-end product sales [1][4]. - The company maintains a high gross margin of 61.07% in 2024, with a slight decrease in net margin to 22.54% [2][4]. Financial Performance Summary - In 2024, the company reported a revenue of 497 million, with a net profit of 112 million, reflecting a year-on-year decrease of 27.79% [5]. - The first quarter of 2025 saw revenues of 132 million, marking a 26.93% increase, and a net profit of 41 million, up 33.96% year-on-year [1][5]. - The gross margin for 2024 was 61.07%, with a net margin of 22.54%, while the first quarter of 2025 showed a gross margin of 61.80% and a net margin of 30.87% [2][4]. Product Development and Market Position - The company has successfully launched high-end products, including an 8GHz, 12-bit high-resolution digital oscilloscope and a 50GHz spectrum analyzer, which have significantly improved performance metrics [3][4]. - High-end product sales increased by 86.60% year-on-year in the first quarter of 2025, contributing to an average price increase of 9.51% for instrument products [3][4]. - The revenue structure has improved, with high-end products accounting for 29% of total revenue, an increase of 8.85 percentage points year-on-year [3][4]. Investment Outlook - The electronic measurement instrument industry is expected to grow steadily, with domestic brands rapidly emerging due to industrial upgrades and self-sufficiency [4]. - The company is positioned as a leader in the domestic electronic measurement instrument market, benefiting from tariff countermeasures and a successful high-end product strategy [4][5]. - Profit forecasts for 2025-2027 have been slightly adjusted, with expected net profits of 167 million, 217 million, and 279 million respectively, corresponding to P/E ratios of 35, 27, and 21 [4][5].

Investment Rating - The investment rating for the company is "Outperform the Market" [6][4]. Core Views - The company achieved a revenue of 497 million yuan in 2024, representing a year-on-year growth of 2.93%, while the net profit attributable to the parent company decreased by 27.79% to 112 million yuan [1]. - The decline in performance in 2024 was primarily due to high R&D and sales expenses, increased exchange losses, and a reduction in government subsidies recognized during the reporting period. However, in the first quarter of 2025, both revenue and profit saw significant growth driven by the increase in high-end product sales [1][4]. - The gross margin for 2024 was 61.07%, with a net margin of 22.54%, indicating a slight decrease compared to the previous year. The company maintained a high level of gross margin while increasing its R&D and sales expenses to support future growth [2][4]. Summary by Sections Financial Performance - In Q4 2024, the company reported a revenue of 143 million yuan, up 6.68% year-on-year, but the net profit decreased by 43.54% to 20 million yuan. In Q1 2025, revenue reached 132 million yuan, a growth of 26.93%, with net profit increasing by 33.96% to 41 million yuan [1][2]. - The company’s revenue forecast for 2025-2027 is adjusted to 621 million yuan, 776 million yuan, and 974 million yuan respectively, with corresponding net profits of 167 million yuan, 217 million yuan, and 279 million yuan [4][5]. Product Development - The company launched several high-end products in 2024, including an 8GHz, 12-bit high-resolution digital oscilloscope and a 50GHz spectrum analyzer, which significantly improved core performance indicators and expanded application ranges [3]. - High-end product sales saw a remarkable increase of 86.60% year-on-year in Q1 2025, contributing to a 9.51% rise in average product prices. The revenue structure shifted, with high-end products accounting for 29% of total revenue, an increase of 8.85 percentage points year-on-year [3]. Market Position and Strategy - The electronic measurement instrument industry is characterized by significant growth potential, and the company is positioned as a leading player in this sector. The ongoing strategy of product high-endization is yielding positive results, supported by domestic demand and tariff policies favoring local brands [4][5]. - The company’s focus on R&D and sales investment is expected to lay a solid foundation for future growth, despite the challenges posed by trade tensions and market competition [4].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is advancing its high-end strategy, with profitability expected to improve in Q1 2025. The company reported a revenue of 497 million yuan in 2024, a year-on-year increase of 2.93%, while the net profit attributable to the parent company was 112 million yuan, a decrease of 27.79% [4][5] - In Q1 2025, the company achieved a revenue of 132 million yuan, representing a year-on-year growth of 26.93%, and a net profit of 41 million yuan, up 33.96% [4][5] - The product structure is continuously optimized, with the revenue share of direct sales increasing. In 2024, the revenue shares of high-end, mid-range, and low-end products were 24%, 54%, and 22%, respectively [5] - The overall gross margin remains high, with a gross margin of 61.07% in 2024 and 61.80% in Q1 2025, driven by the rapid growth of high-end products [6] Financial Performance Summary - The company forecasts revenues of 612 million yuan, 737 million yuan, and 879 million yuan for 2025, 2026, and 2027, respectively, with corresponding net profits of 145 million yuan, 183 million yuan, and 228 million yuan [7][9] - The diluted EPS is projected to be 0.91 yuan, 1.15 yuan, and 1.43 yuan for 2025, 2026, and 2027, respectively [7][9] - The current P/E ratios are 40, 32, and 25 for the years 2025, 2026, and 2027, respectively [7][9]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is advancing its high-end strategy, with profitability expected to improve in Q1 2025. The company reported a steady growth in performance, with 2024 revenue reaching 497 million yuan, a year-on-year increase of 2.93%, and a net profit of 112 million yuan, a decrease of 27.79% [4][5] - The product structure is continuously optimized, with an increase in direct sales revenue proportion. In 2024, high-end products accounted for 24% of revenue, while in Q1 2025, this increased to 29%, reflecting the effectiveness of the high-end strategy [5] - The overall gross margin remains high, with 61.07% in 2024 and 61.80% in Q1 2025, driven by the rapid growth of high-end products. The net profit margin improved significantly in Q1 2025 to 30.87% [6] Financial Performance Summary - For 2024, the company achieved a revenue of 497 million yuan, with a year-on-year growth of 2.93%. The net profit was 112 million yuan, down 27.79% [4][9] - The forecast for 2025-2027 projects revenues of 612 million yuan, 737 million yuan, and 879 million yuan respectively, with net profits of 145 million yuan, 183 million yuan, and 228 million yuan [7][9] - The diluted EPS is expected to be 0.91 yuan, 1.15 yuan, and 1.43 yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 40, 32, and 25 [7][9]